Laforin is a protein encoded by the EPM2A gene and is primarily known for its role in Lafora disease, a fatal autosomal recessive neurodegenerative disorder. Lafora disease is characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies. These inclusions are found in the cytoplasm of cells in the central nervous system and other organs . Laforin is a member of the dual-specificity protein phosphatase family and plays a crucial role in regulating glycogen metabolism and autophagy .
The preparation of mouse anti-human laforin antibodies involves several steps:
Laforin’s primary function is to dephosphorylate glycogen, preventing the formation of poorly branched glycogen that accumulates as Lafora bodies . The protein’s phosphatase activity is crucial for maintaining normal glycogen metabolism. However, recent studies have shown that the phosphatase activity of laforin is not essential for rescuing mice from Lafora disease . Instead, laforin’s role in regulating autophagy and its interaction with the E3 ubiquitin ligase malin are critical for preventing the accumulation of Lafora bodies .
Laforin regulates autophagy via the mammalian target of rapamycin (mTOR) kinase-dependent pathway . The loss of laforin impairs autophagy, leading to the accumulation of autophagy substrates and contributing to cell stress and death . The interaction between laforin and malin is essential for controlling abnormal glycogen accumulation through intracellular proteolytic systems .